JP2023018042A5 - - Google Patents

Download PDF

Info

Publication number
JP2023018042A5
JP2023018042A5 JP2022185110A JP2022185110A JP2023018042A5 JP 2023018042 A5 JP2023018042 A5 JP 2023018042A5 JP 2022185110 A JP2022185110 A JP 2022185110A JP 2022185110 A JP2022185110 A JP 2022185110A JP 2023018042 A5 JP2023018042 A5 JP 2023018042A5
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2022185110A
Other versions
JP2023018042A (ja
Filing date
Publication date
Priority claimed from JP2019536202A external-priority patent/JP2020503353A/ja
Application filed filed Critical
Publication of JP2023018042A publication Critical patent/JP2023018042A/ja
Publication of JP2023018042A5 publication Critical patent/JP2023018042A5/ja
Pending legal-status Critical Current

Links

JP2022185110A 2017-01-04 2022-11-18 寛容原性ペプチドを用いた治療方法 Pending JP2023018042A (ja)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB1700111.6 2017-01-04
GB201700111 2017-01-04
JP2019536202A JP2020503353A (ja) 2017-01-04 2018-01-04 寛容原性ペプチドを用いた治療方法
PCT/IB2018/050061 WO2018127828A1 (en) 2017-01-04 2018-01-04 Therapeutic method using tolerogenic peptides

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2019536202A Division JP2020503353A (ja) 2017-01-04 2018-01-04 寛容原性ペプチドを用いた治療方法

Publications (2)

Publication Number Publication Date
JP2023018042A JP2023018042A (ja) 2023-02-07
JP2023018042A5 true JP2023018042A5 (ja) 2023-08-25

Family

ID=61054439

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2019536202A Pending JP2020503353A (ja) 2017-01-04 2018-01-04 寛容原性ペプチドを用いた治療方法
JP2022185110A Pending JP2023018042A (ja) 2017-01-04 2022-11-18 寛容原性ペプチドを用いた治療方法

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2019536202A Pending JP2020503353A (ja) 2017-01-04 2018-01-04 寛容原性ペプチドを用いた治療方法

Country Status (7)

Country Link
US (1) US20200046802A1 (ja)
EP (1) EP3565585A1 (ja)
JP (2) JP2020503353A (ja)
AU (1) AU2018206356A1 (ja)
CA (1) CA3049177A1 (ja)
WO (1) WO2018127828A1 (ja)
ZA (1) ZA201904384B (ja)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4146190A2 (en) 2020-05-06 2023-03-15 Imcyse SA Combination treatment for fumarate-related diseases

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL215187B1 (pl) * 2000-08-21 2013-11-29 Apitope Technology Bristol Ltd Peptyd tolerogenny, kompozycja farmaceutyczna zawierajaca ten peptyd, peptyd lub kompozycja farmaceutyczna do podawania i zastosowanie peptydu tolerogennego
AU2006203165B2 (en) * 2000-08-21 2009-05-07 Apitope Technology (Bristol) Limited Peptide selection method
GB0202399D0 (en) * 2002-02-01 2002-03-20 Univ Bristol Peptide
PT2211892E (pt) * 2007-10-31 2011-10-18 Apitope Technology Bristol Ltd Composições compreendendo péptidos de proteína básica de mielina e suas utilizações médicas
GB0721430D0 (en) * 2007-10-31 2007-12-12 Apitope Technology Bristol Ltd Composition
GB201314052D0 (en) * 2013-08-06 2013-09-18 Apitope Int Nv Peptides
AU2015370415B2 (en) * 2014-12-24 2022-06-02 Worg Pharmaceuticals (Zhejiang) Co., Ltd. Composition

Similar Documents

Publication Publication Date Title
JP2023018042A5 (ja)
BR102023014872A2 (ja)
BR102023012440A2 (ja)
BR102023009641A2 (ja)
BR102023008688A2 (ja)
BR102023007252A2 (ja)
BR202022009269U2 (ja)
BR202022005961U2 (ja)
BR202022001779U2 (ja)
BR202022000931U2 (ja)
CN307047020S (ja)
BY13165U (ja)
CN307078190S (ja)
CN307077795S (ja)
CN307075792S (ja)
CN307073250S (ja)
CN307067770S (ja)
CN307065746S (ja)
CN307063342S (ja)
CN307060887S (ja)
CN307053937S (ja)
CN307051426S (ja)
CN307047676S (ja)
BY13160U (ja)
CN307046782S (ja)